Tag(s):
Add to My Group
June 21, 2007 at 07:30:10

Did Pfizer's maraviroc whistleblower delay FDA approval of HIV drug?

by Peter Rost     Page 1 of 1 page(s)

http://www.robkall.com


Tell A Friend

The WSJ today penned the headline Pfizer Is Dealt Setback On HIV-Drug Approval.

In the article the WSJ wrote about the new drug maraviroc: "Pfizer Inc.'s pipeline was dealt a surprise blow last night, when the FDA delayed the approval of one of its most interesting drug prospects, a new type of medicine for HIV."



The WSJ also said that "The FDA isn't asking for any more clinical trials."

The FDA apparently couldn't be reached for comment last night.

So did the allegations related to illegal premarketing of maraviroc result in this debacle?

Make up your own mind and read all the maraviroc allegations by Pfizer's internal whistleblower here.

 

Peter Rost, M.D., is a former Vice President of Pfizer. He is the author of "The Whistleblower, Confessions of a Healthcare Hitman." He also writes the daily Dr. Peter Rost blog.

Contact Author

Contact Editor

View Other Articles by Author

 

Bookmark this page: (what's this?)

NETSCAPE      DIGG THIS      NEWSVINE      DEl.ICIO.US      Looksmart Furl      My Web      Spurl      Tag!RawSugar      Shadows Tag!      Blink List     (More...)
Comments: Expand   Shrink   Hide  
No comments

 

Tell A Friend

 


Copyright © OpEdNews, 2002-2007

 

Tags for This Article:

Fraud (28) 

Populum Tag Cloud
Control Panel
Fine tune your search to access content
All Articles
Diaries
All time
Last 6 mos
Last month
Last week
Last 24 hrs
From:
Month  Day   Year

To:
Month  Day   Year
Alphabet
Popularity
Count ON
Count OFF
This Level
Also Sub-levels